Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
- PMID: 37776353
- PMCID: PMC10627898
- DOI: 10.1007/s00401-023-02638-1
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
Figures

Comment in
-
Pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion. Scientific commentary on 'Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics'.Acta Neuropathol. 2024 Feb 10;147(1):34. doi: 10.1007/s00401-024-02684-3. Acta Neuropathol. 2024. PMID: 38340187 Free PMC article. No abstract available.
References
-
- Kerezoudis P, Yolcu YU, Laack NN, Ruff MW, Khatua S, Daniels DJ, et al. Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: insights from the National Cancer Database. Neurooncol Adv. 2022;4(1):vdac057. doi: 10.1093/noajnl/vdac057. - DOI - PMC - PubMed
-
- Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. 2019;137(5):851–854. doi: 10.1007/s00401-019-01990-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical